IMMUTEP LTD ORDINARY (IMM) Short Interest

IMMUTEP LTD ORDINARY (ASX:IMM) had 2.78% of shares reported as short positions as of 16 May 2026, representing 41,031,210 shares. IMMUTEP LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest
2.78%
Reported positions
41,031,210
Industry
Pharmaceuticals, Biotechnology & Life Sciences
As of
16 May 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Immutep logo

IMM

Immutep

Pharmaceuticals, Biotechnology & Life Sciences

Immutep is a biotechnology company focused on developing LAG-3 related immunotherapy products for the treatment of cancer and autoimmune diseases. The company is pioneering the LAG-3 space and has clinical-stage assets targeting areas of high unmet need.

biotechnology
pharmaceuticals
immunotherapy
oncology

Shorted

short percentage2.78%
reported shorts41M
shares on issue1.474B